+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hormonal Contraceptives Market Research Report by Hormone Type, by Method Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5206450
  • Report
  • July 2021
  • Region: Global
  • 194 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Hormonal Contraceptives Market will Grow to USD 20.89 Billion by 2026, at a CAGR of 6.57%

FEATURED COMPANIES

  • AbbVie Inc.
  • Agile Therapeutics
  • Ansell Ltd
  • Boehringer Ingelheim GmbH
  • Covetrus, Inc.
  • HLL Lifecare Limited
The Global Hormonal Contraceptives Market size was estimated at USD 14.25 Billion in 2020 and expected to reach USD 15.14 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 6.57% to reach USD 20.89 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Hormonal Contraceptives to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Hormone Type, the Hormonal Contraceptives Market was studied across Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens.
  • Based on End-user, the Hormonal Contraceptives Market was studied across Ambulatory Surgical Centers, Gynecology Centers, Homecare, and Hospitals & Clinics.
  • Based on Method Type, the Hormonal Contraceptives Market was studied across Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Oral Contraceptives, Transdermal Patch, and Vaginal Ring.
  • Based on Region, the Hormonal Contraceptives Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hormonal Contraceptives Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hormonal Contraceptives Market, including AbbVie Inc., Afaxys, Inc, Agile Therapeutics, Amgen Inc., Ansell Ltd, Apothecus Pharmaceutical Corporation, Bayer AG, BioSante Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Church & Dwight, Co., Inc., Cipla Limited, Covetrus, Inc., Glenmark Pharmaceuticals, HLL Lifecare Limited, Johnson & Johnson Services, Inc, Lupin Pharmaceuticals, Inc., Mayer Laboratories, Inc, Merck & Co. Inc., Mylan N.V, Novartis International AG, Pfizer, Inc., Piramal Healthcare Limited, Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries, Vardhman Life Care Pvt. Ltd., and Warner Chilcott Company.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Hormonal Contraceptives Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hormonal Contraceptives Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hormonal Contraceptives Market?
4. What is the competitive strategic window for opportunities in the Global Hormonal Contraceptives Market?
5. What are the technology trends and regulatory frameworks in the Global Hormonal Contraceptives Market?
6. What is the market share of the leading vendors in the Global Hormonal Contraceptives Market?
7. What modes and strategic moves are considered suitable for entering the Global Hormonal Contraceptives Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Agile Therapeutics
  • Ansell Ltd
  • Boehringer Ingelheim GmbH
  • Covetrus, Inc.
  • HLL Lifecare Limited
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Hormone Type Outlook
3.4. End-user Outlook
3.5. Method Type Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness about the benefits and use of contraceptives
5.1.1.2. Government initiatives to promote the use of contraceptives
5.1.1.3. Need for oral contraceptives as a preferred method to avoid unplanned pregnancy
5.1.2. Restraints
5.1.2.1. Growing use of biologics instead of traditional chemical drugs
5.1.3. Opportunities
5.1.3.1. Increasing demand for a healthy life in emerging economies
5.1.3.2. Technological advancements in contraceptive methods
5.1.4. Challenges
5.1.4.1. Limited social acceptance
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Hormonal Contraceptives Market, by Hormone Type
6.1. Introduction
6.2. Androgens
6.3. Antiandrogens
6.4. Estrogens
6.5. Gonadotropins
6.6. Progestogens

7. Hormonal Contraceptives Market, by End-user
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Gynecology Centers
7.4. Homecare
7.5. Hospitals & Clinics

8. Hormonal Contraceptives Market, by Method Type
8.1. Introduction
8.2. Combined Oral Contraceptives
8.3. Implanted Contraceptives
8.4. Injected Contraceptives
8.5. Intrauterine
8.6. Oral Contraceptives
8.7. Transdermal Patch
8.8. Vaginal Ring

9. Americas Hormonal Contraceptives Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Hormonal Contraceptives Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Hormonal Contraceptives Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AbbVie Inc.
13.2. Afaxys, Inc
13.3. Agile Therapeutics
13.4. Amgen Inc.
13.5. Ansell Ltd
13.6. Apothecus Pharmaceutical Corporation
13.7. Bayer AG
13.8. BioSante Pharmaceuticals Inc.
13.9. Boehringer Ingelheim GmbH
13.10. Church & Dwight, Co., Inc.
13.11. Cipla Limited
13.12. Covetrus, Inc.
13.13. Glenmark Pharmaceuticals
13.14. HLL Lifecare Limited
13.15. Johnson & Johnson Services, Inc
13.16. Lupin Pharmaceuticals, Inc.
13.17. Mayer Laboratories, Inc
13.18. Merck & Co. Inc.
13.19. Mylan N.V
13.20. Novartis International AG
13.21. Pfizer, Inc.
13.22. Piramal Healthcare Limited
13.23. Reckitt Benckiser Group PLC
13.24. Sun Pharmaceutical Industries Ltd.
13.25. Teva Pharmaceutical Industries
13.26. Vardhman Life Care Pvt. Ltd.
13.27. Warner Chilcott Company

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 (USD BILLION)
FIGURE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 (USD BILLION)
FIGURE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 (USD BILLION)
FIGURE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 VS 2026 (%)
FIGURE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2026
FIGURE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 23. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2026
FIGURE 25. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, 2018-2026 (USD BILLION)
FIGURE 30. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 31. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2026 (USD BILLION)
FIGURE 32. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 33. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 VS 2026 (%)
FIGURE 34. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2026
FIGURE 36. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, 2018-2026 (USD BILLION)
FIGURE 39. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 40. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, 2018-2026 (USD BILLION)
FIGURE 41. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 42. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, 2018-2026 (USD BILLION)
FIGURE 43. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 44. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2026 (USD BILLION)
FIGURE 45. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 46. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2026 (USD BILLION)
FIGURE 47. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 48. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, 2018-2026 (USD BILLION)
FIGURE 49. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 50. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 70. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 71. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 72. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 73. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 74. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 75. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 76. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 77. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 78. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 79. GLOBAL HORMONAL CONTRACEPTIVES MARKET: FPNV POSITIONING MATRIX
FIGURE 80. GLOBAL HORMONAL CONTRACEPTIVES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL HORMONAL CONTRACEPTIVES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2026 (USD BILLION)
TABLE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2018-2026 (USD BILLION)
TABLE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, BY REGION, 2018-2026 (USD BILLION)
TABLE 23. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 50. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 51. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 52. GLOBAL HORMONAL CONTRACEPTIVES MARKET: SCORES
TABLE 53. GLOBAL HORMONAL CONTRACEPTIVES MARKET: BUSINESS STRATEGY
TABLE 54. GLOBAL HORMONAL CONTRACEPTIVES MARKET: PRODUCT SATISFACTION
TABLE 55. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RANKING
TABLE 56. GLOBAL HORMONAL CONTRACEPTIVES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 57. GLOBAL HORMONAL CONTRACEPTIVES MARKET: MERGER & ACQUISITION
TABLE 58. GLOBAL HORMONAL CONTRACEPTIVES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 59. GLOBAL HORMONAL CONTRACEPTIVES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 60. GLOBAL HORMONAL CONTRACEPTIVES MARKET: INVESTMENT & FUNDING
TABLE 61. GLOBAL HORMONAL CONTRACEPTIVES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 62. GLOBAL HORMONAL CONTRACEPTIVES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Afaxys, Inc
  • Agile Therapeutics
  • Amgen Inc.
  • Ansell Ltd
  • Apothecus Pharmaceutical Corporation
  • Bayer AG
  • BioSante Pharmaceuticals Inc.
  • Boehringer Ingelheim GmbH
  • Church & Dwight, Co., Inc.
  • Cipla Limited
  • Covetrus, Inc.
  • Glenmark Pharmaceuticals
  • HLL Lifecare Limited
  • Johnson & Johnson Services, Inc
  • Lupin Pharmaceuticals, Inc.
  • Mayer Laboratories, Inc
  • Merck & Co. Inc.
  • Mylan N.V
  • Novartis International AG
  • Pfizer, Inc.
  • Piramal Healthcare Limited
  • Reckitt Benckiser Group PLC
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries
  • Vardhman Life Care Pvt. Ltd.
  • Warner Chilcott Company
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll